Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lispro-PH20 and Aspart-PH20 in Type 1 Diabetes
NCT01194245Phase 2Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started Aug 2010; status: completed.
02
Drugs
hyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01194245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194245.